- Home
- CLRB vs SNES Comparison
CLRB vs SNES Comparison
Compare CLRB & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLRB | SNES |
|---|---|---|
| Founded | 2002 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 12.1M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CLRB | SNES |
|---|---|---|
| Price | $3.56 | $1.95 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 130.0K | 40.6K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,301,000.00 |
| Revenue This Year | N/A | $41.52 |
| Revenue Next Year | N/A | $77.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 39.37 |
| 52 Week Low | $2.45 | $1.30 |
| 52 Week High | $20.60 | $6.24 |
Technical Indicators
Market Signals| Indicator | CLRB | SNES |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 30.06 |
| Support Level | $3.33 | $2.03 |
| Resistance Level | $3.98 | $2.12 |
| Average True Range (ATR) | 0.30 | 0.08 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 53.85 | 12.05 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.